PMV PHARMACEUTICALS, INC. Earnings Per Share (Basic)
PMV PHARMACEUTICALS, INC. (PMVP) reported Earnings Per Share (Basic) of -$0.34 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- PMV PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.34.
- PMV PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.34.
- PMV PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.34.
- PMV PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.40.
- PMV PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2025 was -$1.48.
- PMV PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2024 was -$1.14.
- PMV PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2023 was -$1.44.
- PMV PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2022 was -$1.61.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.34 10-Q · filed 2026-08-14 | -$0.68 10-Q · filed 2026-08-14 | -$1.02 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.41 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2026-03-31 | -$0.34 10-Q · filed 2026-05-12 | -$0.68 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.07 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.48 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-12-31 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$1.14 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.48 10-K · filed 2026-03-06 |
| 2025-09-30 | -$0.40 10-Q · filed 2025-11-12 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.14 10-Q · filed 2025-11-12 | -$1.59 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-06-30 | -$0.41 10-Q · filed 2026-08-14 | -$0.74 10-Q · filed 2026-08-14 | -$1.19 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.56 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-03-31 | -$0.34 10-Q · filed 2026-05-12 | -$0.78 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.16 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$1.18 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2024-12-31 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$0.82 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$0.85 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$1.14 10-K · filed 2026-03-06 |
| 2024-09-30 | -$0.37 10-Q · filed 2025-11-12 | -$0.40 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$0.69 10-Q · filed 2025-11-12 | -$1.00 derived: net income ÷ weighted average shares · filed 2026-04-22 |
| 2024-06-30 | -$0.02 10-Q · filed 2025-08-07 | -$0.32 10-Q · filed 2025-08-07 | -$0.63 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$0.96 derived: net income ÷ weighted average shares · filed 2026-04-22 |
| 2024-03-31 | -$0.30 10-Q · filed 2025-05-09 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$0.94 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$1.32 derived: net income ÷ weighted average shares · filed 2026-04-22 |
| 2023-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$1.02 derived: net income ÷ weighted average shares · filed 2026-04-22 | -$1.44 10-K · filed 2026-03-06 |
| 2023-09-30 | -$0.34 10-Q · filed 2024-11-07 | -$0.72 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$1.13 10-Q · filed 2024-11-07 | -$1.56 derived: net income ÷ weighted average shares · filed 2025-03-03 |
| 2023-06-30 | -$0.38 10-Q · filed 2024-08-08 | -$0.80 10-Q · filed 2024-08-08 | -$1.22 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$1.62 derived: net income ÷ weighted average shares · filed 2025-03-03 |
| 2023-03-31 | -$0.42 10-Q · filed 2024-05-09 | -$0.84 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$1.24 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$1.62 derived: net income ÷ weighted average shares · filed 2025-03-03 |
| 2022-12-31 | -$0.42 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$0.82 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$1.20 derived: net income ÷ weighted average shares · filed 2025-03-03 | -$1.61 10-K · filed 2025-03-03 |
| 2022-09-30 | -$0.40 10-Q · filed 2023-11-09 | -$0.78 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.18 10-Q · filed 2023-11-09 | -$1.59 derived: net income ÷ weighted average shares · filed 2024-02-29 |
| 2022-06-30 | -$0.38 10-Q · filed 2023-08-09 | -$0.79 10-Q · filed 2023-08-09 | -$1.19 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.52 derived: net income ÷ weighted average shares · filed 2024-02-29 |
| 2022-03-31 | -$0.41 10-Q · filed 2023-05-10 | -$0.81 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.14 derived: net income ÷ weighted average shares · filed 2024-02-29 | |
| 2021-12-31 | -$0.40 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$0.74 derived: net income ÷ weighted average shares · filed 2024-02-29 | -$1.28 10-K · filed 2024-02-29 | |
| 2021-09-30 | -$0.33 10-Q · filed 2022-11-08 | -$0.88 10-Q · filed 2022-11-08 | ||
| 2020-12-31 | -$2.40 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |